Literature DB >> 25317789

Adverse skin reaction caused by dabigatran.

M A Cakmak1, S Sahin, N Cinar, S Karsidag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25317789

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN： 1128-3602            Impact factor:   3.507


× No keyword cloud information.
  4 in total

1.  Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism.

Authors:  Hong Lyeol Lee; Lucia Kim; Cheol Woo Kim; Jung Soo Kim; Hae Sung Nam; Jeong Seon Ryu
Journal:  Respir Med Case Rep       Date:  2019-01-25

2.  Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Authors:  Mohamed Mohamoud; Casie Horgan; Efe Eworuke; Elizabeth Dee; Justin Bohn; Oren Shapira; Monica A Munoz; Danijela Stojanovic; Veronica Sansing-Foster; Adebola Ajao; Lois La Grenade
Journal:  Pharmacotherapy       Date:  2020-11-08       Impact factor: 6.251

3.  Dabigatran Associated Leukocytoclastic Vasculitis.

Authors:  Evangelos Potolidis; Charalampos Mandros; Kalliopi Kotsa; Evdoxia Mitsiou; Dimitris Potolidis; Panagiotis Fanourgiakis
Journal:  Case Rep Med       Date:  2015-12-30

4.  Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.

Authors:  Géric Maura; Cécile Billionnet; Joël Coste; Alain Weill; Anke Neumann; Antoine Pariente
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.